Nomura Holdings Inc. Purchases New Shares in Pediatrix Medical Group, Inc. (NYSE:MD)

Nomura Holdings Inc. purchased a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 295,919 shares of the company's stock, valued at approximately $3,882,000. Nomura Holdings Inc. owned about 0.34% of Pediatrix Medical Group at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. grew its position in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust grew its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares during the last quarter. AlphaQuest LLC grew its position in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares during the last quarter. Smartleaf Asset Management LLC grew its position in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after buying an additional 6,090 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after purchasing an additional 5,104 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. UBS Group reduced their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 12th. Truist Financial reduced their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Macquarie upped their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Finally, StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Stock Down 0.6%

NYSE MD traded down $0.09 on Monday, hitting $14.84. 731,044 shares of the company were exchanged, compared to its average volume of 852,625. The company has a market cap of $1.27 billion, a PE ratio of -12.37, a PEG ratio of 1.74 and a beta of 1.26. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The stock has a fifty day moving average of $13.71 and a 200-day moving average of $14.12. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.08. The business had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Pediatrix Medical Group's revenue was down 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.20 earnings per share. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.